Back to Cancer Australia’s website

Home
About Us
About Clinical Trials
Search clinical trials
Glossary
Question Prompt Lists

Home
About Us
About clinical trials
Search clinical trials
Glossary
Question Prompt Lists

Home
Gemtuzumab (Mylotarg)

Gemtuzumab (Mylotarg)

An antibody against the CD33 antigen used in the treatment of CD33 positive acute non-lymphocytic leukaemia.

Quick Links

About clinical trials
Advanced search

Partners

RGB_Cancer Australia white inline

Australian Cancer Trials is not designed to provide medical advice or professional services and is intended to be for informational use only. The information provided through Australian Cancer Trials is not a substitute for professional care and should not be used for diagnosing or treating a health problem or a disease. If you have, or suspect you may have, a health problem consult your doctor.

About clinical trials

Search clinical trials

Questions prompts

© 2025 Australian Cancer Trials

Site map
Copyright
Privacy policy
Disclaimers